Wang, P., Y. Song, Z. Liu, H. Wang, W. Zheng, S. Liu, Z. Feng, J. Zhai, C. Yao, M. Ren, C. Bai, and H. Shang. 2016. Xuebijing injection in the treatment of severe pneumonia: Study protocol for a randomized controlled trial. Trials 17 (1): 142. https://doi.org/10.1186/s13063-016-1282-8.
CAS Article PubMed PubMed Central Google Scholar
Tang, H., Z. Yuan, J. Li, Q. Wang, and W. Fan. 2022. The application of ambroxol hydrochloride combined with fiberoptic bronchoscopy in elderly patients with severe pneumonia: A meta-analysis and systematic review. Medicine (Baltimore) 101 (4): e28535. https://doi.org/10.1097/MD.0000000000028535.
Jiang, H., W. Guo, Z. Shi, H. Jiang, M. Zhang, L. Wei, and Y. Pan. 2020. Clinical imaging characteristics of inpatients with coronavirus disease-2019 in Heilongjiang Province, China: A retrospective study. Aging (Albany NY) 12 (14): 13860–13868. https://doi.org/10.18632/aging.103633.
Li, Y., W. Sun, H. Pan, J. Yuan, Q. Xu, T. Xu, P. Li, D. Cheng, Y. Liu, and C. Ni. 2021. LncRNA-PVT1 activates lung fibroblasts via miR-497-5p and is facilitated by FOXM1. Ecotoxicology and Environmental Safety 213: 112030. https://doi.org/10.1016/j.ecoenv.2021.112030.
CAS Article PubMed Google Scholar
Chen, R., W.X. Li, Y. Sun, Y. Duan, Q. Li, A.X. Zhang, J.L. Hu, Y.M. Wang, and Y.D. Gao. 2017. Comprehensive analysis of lncRNA and mRNA expression profiles in lung cancer. Clinical Laboratory 63 (2): 313–320. https://doi.org/10.7754/Clin.Lab.2016.160812.
CAS Article PubMed Google Scholar
Huang, Y. 2018. The novel regulatory role of lncRNA-miRNA-mRNA axis in cardiovascular diseases. Journal of Cellular and Molecular Medicine 22 (12): 5768–5775. https://doi.org/10.1111/jcmm.13866.
CAS Article PubMed PubMed Central Google Scholar
Cao, H.L., Z.J. Liu, P.L. Huang, Y.L. Yue, and J.N. Xi. 2019. lncRNA-RMRP promotes proliferation, migration and invasion of bladder cancer via miR-206. European Review for Medical and Pharmacological Sciences 23 (3): 1012–1021. https://doi.org/10.26355/eurrev_201902_16988.
Jia, J., X. Liu, L. Ma, Y. Xu, and Y. Ren. 2021. A preliminary analysis of LncRNA biomarkers for schizophrenia. Epigenomics 13 (18): 1443–1458. https://doi.org/10.2217/epi-2021-0223.
CAS Article PubMed Google Scholar
Huang, K., C. Wang, C. Vagts, V. Raguveer, P.W. Finn, and D.L. Perkins. 2022. Long non-coding RNAs (lncRNAs) NEAT1 and MALAT1 are differentially expressed in severe COVID-19 patients: An integrated single-cell analysis. PLoS ONE 17 (1): e0261242. https://doi.org/10.1371/journal.pone.0261242.
CAS Article PubMed PubMed Central Google Scholar
Guo, J., N. Zhang, G. Liu, A. Zhang, X. Liu, and J. Zheng. 2021. Upregulated expression of long non-coding RNA MEG3 serves as a prognostic biomarker in severe pneumonia children and its regulatory mechanism. Bioengineered 12 (1): 7120–7131. https://doi.org/10.1080/21655979.2021.1979351.
CAS Article PubMed PubMed Central Google Scholar
Yan, L.P., Z.B. Liu, M. Wu, Y.P. Ge, and Q. Zhang. 2020. Effect of lncRNA MALAT1 expression on survival status of elderly patients with severe pneumonia. European Review for Medical and Pharmacological Sciences 24 (7): 3959–3964. https://doi.org/10.26355/eurrev_202004_20865.
Zhang, W., L. Chen, J. Wu, J. Li, X. Zhang, Y. Xiang, F. Li, C. Wu, L. Xiang, Q. Ran, and Z. Li. 2019. Long noncoding RNA TUG1 inhibits osteogenesis of bone marrow mesenchymal stem cells via Smad5 after irradiation. Theranostics 9 (8): 2198–2208. https://doi.org/10.7150/thno.30798.
CAS Article PubMed PubMed Central Google Scholar
Guo, C., Y. Qi, J. Qu, L. Gai, Y. Shi, and C. Yuan. 2020. Pathophysiological functions of the lncRNA TUG1. Current Pharmaceutical Design 26 (6): 688–700. https://doi.org/10.2174/1381612826666191227154009.
CAS Article PubMed Google Scholar
Su, Q., Y. Liu, X.W. Lv, R.X. Dai, X.H. Yang, and B.H. Kong. 2020. LncRNA TUG1 mediates ischemic myocardial injury by targeting miR-132-3p/HDAC3 axis. American Journal of Physiology. Heart and Circulatory Physiology 318 (2): H332–H344. https://doi.org/10.1152/ajpheart.00444.2019.
CAS Article PubMed Google Scholar
Long, J., S.S. Badal, Z. Ye, Y. Wang, B.A. Ayanga, D.L. Galvan, N.H. Green, B.H. Chang, P.A. Overbeek, and F.R. Danesh. 2016. Long noncoding RNA Tug1 regulates mitochondrial bioenergetics in diabetic nephropathy. The Journal of Clinical Investigation 126 (11): 4205–4218. https://doi.org/10.1172/JCI87927.
Article PubMed PubMed Central Google Scholar
Qiu, N., X. Xu, and Y. He. 2020. LncRNA TUG1 alleviates sepsis-induced acute lung injury by targeting miR-34b-5p/GAB1. BMC Pulmonary Medicine 20 (1): 49. https://doi.org/10.1186/s12890-020-1084-3.
CAS Article PubMed PubMed Central Google Scholar
Yang, L., L. Zhao, H. Zhang, and P. Chen. 2021. Up-regulation of TUG1 can regulate miR-494/PDK4 axis to inhibit LPS-induced acute lung injury caused by sepsis. Am J Transl Res 13 (11): 12375–12385.
CAS PubMed PubMed Central Google Scholar
Ticona, J.H., V.M. Zaccone, and I.M. McFarlane. 2021. Community-acquired pneumonia: A focused review. Am J Med Case Rep 9 (1): 45–52. https://doi.org/10.12691/ajmcr-9-1-12.
Najafi, S., and C. Sandrock. 2017. Hospitalized patients with acute pneumonia. Hosp Med Clin 6 (4): 456–469. https://doi.org/10.1016/j.ehmc.2017.05.012.
Article PubMed PubMed Central Google Scholar
Dahn, C.M., O. Wijesekera, G.E. Garcia, K. Karasek, and G.A. Jacquet. 2018. Acute care for the three leading causes of mortality in lower-middle-income countries: A systematic review. International Journal of Critical Illness and Injury Science 8 (3): 117–142. https://doi.org/10.4103/IJCIIS.IJCIIS_22_18.
Article PubMed PubMed Central Google Scholar
Yang, Q., J. Wang, P. Zhong, T. Mou, H. Hua, P. Liu, and F. Xie. 2020. The clinical prognostic value of lncRNA FAM83H-AS1 in cancer patients: A meta-analysis. Cancer Cell International 20: 72. https://doi.org/10.1186/s12935-020-1148-8.
CAS Article PubMed PubMed Central Google Scholar
Huang, S., C. Feng, L. Chen, Z. Huang, X. Zhou, B. Li, L.L. Wang, W. Chen, F.Q. Lv, and T.S. Li. 2016. Identification of potential key long non-coding RNAs and target genes associated with pneumonia using long non-coding RNA sequencing (lncRNA-Seq): A preliminary study. Medical Science Monitor 22: 3394–3408. https://doi.org/10.12659/msm.900783.
CAS Article PubMed PubMed Central Google Scholar
Liu, H., G. Zhou, X. Fu, H. Cui, G. Pu, Y. Xiao, W. Sun, X. Dong, L. Zhang, S. Cao, G. Li, X. Wu, and X. Yang. 2017. Long noncoding RNA TUG1 is a diagnostic factor in lung adenocarcinoma and suppresses apoptosis via epigenetic silencing of BAX. Oncotarget 8 (60): 101899–101910. https://doi.org/10.18632/oncotarget.22058.
Article PubMed PubMed Central Google Scholar
Guo, S., Y. Yin, Z. Wang, Z. Wu, L. Zhang, Z. Niu, and C. Yin. 2020. lncRNA TUG1 Expression in NSCLC and its clinical significance. Clinical Laboratory 66 (10). https://doi.org/10.7754/Clin.Lab.2020.200217.
Watanabe, N., S. Yokoe, Y. Ogata, S. Sato, and K. Imai. 2020. Exposure to Porphyromonas gingivalis induces production of proinflammatory cytokine via TLR2 from human respiratory epithelial cells. Journal of Clinical Medicine 9 (11). https://doi.org/10.3390/jcm9113433.
Yin, J., and C.X. Bai. 2018. Pharmacotherapy for adult patients with acute respiratory distress syndrome. Chinese Medical Journal (Engl) 131 (10): 1138–1141. https://doi.org/10.4103/0366-6999.231520.
Gumus, A., N. Altintas, H. Cinarka, A. Kirbas, M. Haziroglu, M. Karatas, and U. Sahin. 2015. Soluble urokinase-type plasminogen activator receptor is a novel biomarker predicting acute exacerbation in COPD. International Journal of Chronic Obstructive Pulmonary Disease 10: 357–365. https://doi.org/10.2147/COPD.S77654.
Article PubMed PubMed Central Google Scholar
Lagha, A.B., and D. Grenier. 2016. Tea polyphenols inhibit the activation of NF-kappaB and the secretion of cytokines and matrix metalloproteinases by macrophages stimulated with Fusobacterium nucleatum. Science and Reports 6: 34520. https://doi.org/10.1038/srep34520.
Liu, Q.M., L.L. Liu, X.D. Li, P. Tian, H. Xu, Z.L. Li, and L.K. Wang. 2020. Silencing lncRNA TUG1 alleviates LPS-induced mouse hepatocyte inflammation by targeting miR-140/TNF. Front Cell Dev Biol 8: 616416. https://doi.org/10.3389/fcell.2020.616416.
Kruger, S., Ewig, S., Marre, R., Papassotiriou, J., Richter, K., von Baum, H., Suttorp, N., Welte, T., and Group CS. 2008. Procalcitonin predicts patients at low risk of death from community-acquired pneumonia across all CRB-65 classes. European Respiratory Journal 31 (2): 349–355. https://doi.org/10.1183/09031936.00054507.
Christ-Crain, M., N.G. Morgenthaler, D. Stolz, C. Muller, R. Bingisser, S. Harbarth, M. Tamm, J. Struck, A. Bergmann, and B. Muller. 2006. Pro-adrenomedullin to predict severity and outcome in community-acquired pneumonia [ISRCTN04176397]. Critical Care 10 (3): R96. https://doi.org/10.1186/cc4955.
Article PubMed PubMed Central Google Scholar
Menendez, R., R. Martinez, S. Reyes, J. Mensa, X. Filella, M.A. Marcos, A. Martinez, C. Esquinas, P. Ramirez, and A. Torres. 2009. Biomarkers improve mortality prediction by prognostic scales in community-acquired pneumonia. Thorax 64 (7): 587–591. https://doi.org/10.1136/thx.2008.105312.
留言 (0)